Delivery Order SPE2DB22D1106-SPE2DB24FFGR7
Award Date
8/14/24
Potential Completion Date
9/5/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 Firm Fixed Price Delivery Order contract is for VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,738.20, is for the provision of VENCLEXTA 100 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,056.00 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide VENCLEXTA 50 MG TABLET UD 7S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 2025, which allows DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department of Defense. Amerisourcebergen has also been awarded a...
This is a $8,880.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,266,344 units of the prescription drug VENCLEXTA 100 mg tablets. The contract has an ultimate completion date of August 16, 2024 and was awarded on July 26, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide the medication VENCLEXTA 50 MG TABLET UD 7S. This delivery order contract has a performance period through March 15, 2024 and is related to a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,140,312 units of the prescription medication Venclexta 100 mg tablets. The contract has a ceiling value of $9,728.17 and a performance period ending on May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen, valued at $999,999,999.00, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,458,575 units of the pharmaceutical product VENCLEXTA 100 MG TABLET. The contract, with a potential value of $17,760.30, has a completion date of February 16, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to support military treatment programs and facilities....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,880,578 units of the prescription medication VENCLEXTA 100 MG TABLET. The contract has a potential value of $8,880.15 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 contract is for the supply of 4,567,998,903 units of the prescription medication Venclexta 100 mg tablets. The award has an ultimate completion date of May 13, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,728.17, is for the delivery of VENCLEXTA 100 MG TABLET UU 120S. This is a Firm Fixed Price Delivery Order contract with a period of performance through February 4, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...